Cargando…
CD30(+) lymphomatoid skin toxicity secondary to ipilimumab
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082605/ https://www.ncbi.nlm.nih.gov/pubmed/32211493 http://dx.doi.org/10.1016/j.jdcr.2016.07.008 |
_version_ | 1783508379025539072 |
---|---|
author | Bush, Amelia E. Garcia, Andres Li, Janet Curry, Jonathan Chon, Susan Y. |
author_facet | Bush, Amelia E. Garcia, Andres Li, Janet Curry, Jonathan Chon, Susan Y. |
author_sort | Bush, Amelia E. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7082605 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-70826052020-03-24 CD30(+) lymphomatoid skin toxicity secondary to ipilimumab Bush, Amelia E. Garcia, Andres Li, Janet Curry, Jonathan Chon, Susan Y. JAAD Case Rep Case Report Elsevier 2020-03-19 /pmc/articles/PMC7082605/ /pubmed/32211493 http://dx.doi.org/10.1016/j.jdcr.2016.07.008 Text en © 2016 Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Bush, Amelia E. Garcia, Andres Li, Janet Curry, Jonathan Chon, Susan Y. CD30(+) lymphomatoid skin toxicity secondary to ipilimumab |
title | CD30(+) lymphomatoid skin toxicity secondary to ipilimumab |
title_full | CD30(+) lymphomatoid skin toxicity secondary to ipilimumab |
title_fullStr | CD30(+) lymphomatoid skin toxicity secondary to ipilimumab |
title_full_unstemmed | CD30(+) lymphomatoid skin toxicity secondary to ipilimumab |
title_short | CD30(+) lymphomatoid skin toxicity secondary to ipilimumab |
title_sort | cd30(+) lymphomatoid skin toxicity secondary to ipilimumab |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082605/ https://www.ncbi.nlm.nih.gov/pubmed/32211493 http://dx.doi.org/10.1016/j.jdcr.2016.07.008 |
work_keys_str_mv | AT bushameliae cd30lymphomatoidskintoxicitysecondarytoipilimumab AT garciaandres cd30lymphomatoidskintoxicitysecondarytoipilimumab AT lijanet cd30lymphomatoidskintoxicitysecondarytoipilimumab AT curryjonathan cd30lymphomatoidskintoxicitysecondarytoipilimumab AT chonsusany cd30lymphomatoidskintoxicitysecondarytoipilimumab |